Skip to main content
. 2021 Mar 30;35(7):2076–2085. doi: 10.1038/s41375-021-01213-5

Fig. 1. Overall survival, disease-free survival, relapse, and non-relapse mortality from first complete remission (CR1) of chemotherapy (chemo) and allogeneic HCT (HCT) cohorts.

Fig. 1

Upper left, adjusted overall survival; upper right, adjusted disease-free survival; lower left, cumulative incidence of relapse; lower right, cumulative incidence of non-relapse mortality.